Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression

Objectives To determine the proportion, characteristics and outcomes of patients who transfer-out from an antiretroviral therapy (ART) service in a South African township. Methods This retrospective cohort study included all patients aged ≥15 years who enrolled between September 2002 and December 2009. Follow-up data were censored in December 2010. Kaplan-Meier survival analysis was used to describe time to transfer-out and cox proportional hazard analysis was used to determine associated risk factors. Results 4511 patients (4003 ART-naïve and 508 non-naïve at baseline) received ART during the study period. Overall, 597 (13.2%) transferred out. The probability of transferring out by one year of ART steadily increased from 1.4% in 2002/2004 cohort to 8.9% for the 2009 cohort. Independent risk factors for transfer-out were more recent calendar year of enrolment, younger age (≤25 years) and being ART non-naïve at baseline (i.e., having previously transferred into this clinic from another facility). The proportions of patients transferred out who had a CD4 cell count <200 cells/µL and/or a viral load ≥1000 copies/mL were 19% and 20%, respectively. Conclusions With scale-up of ART over time, an increasing proportion of patients are transferring between ART services and information systems are needed to track patients. Approximately one-fifth of these have viral loads >1000 copies/mL around the time of transfer, suggesting the need for careful adherence counseling and assessment of medication supplies among those planning transfer.

[1]  S. Charalambous,et al.  A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa , 2011, BMC health services research.

[2]  S. Lawn,et al.  Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[3]  S. Lawn,et al.  Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa , 2011, Journal of acquired immune deficiency syndromes.

[4]  U. Unicef,et al.  Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. , 2011 .

[5]  L. Myer,et al.  Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007 , 2010, AIDS.

[6]  Roger Paredes,et al.  Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. , 2010, The Journal of infectious diseases.

[7]  B. Rau,et al.  Decentralizing antiretroviral treatment services at primary health care facilities: a guide to expanding access and care in resource-limited, generalized HIV epidemic settings , 2010 .

[8]  L. Myer,et al.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa , 2008, AIDS.

[9]  Karen Cohen,et al.  Antiretroviral therapy and early mortality in South Africa. , 2008, Bulletin of the World Health Organization.

[10]  L. Myer,et al.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. , 2008, Bulletin of the World Health Organization.

[11]  E. Schouten,et al.  What Happens to Patients on Antiretroviral Therapy Who Transfer Out to Another Facility? , 2008, PloS one.

[12]  Sydney Rosen,et al.  Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.

[13]  L. Myer,et al.  Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control , 2006, AIDS.

[14]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.

[15]  L. Myer,et al.  Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design , 2005, AIDS.

[16]  I. Thior,et al.  Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana , 2005, Journal of acquired immune deficiency syndromes.

[17]  C. Sabin,et al.  Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre , 2001, AIDS.

[18]  M. Moroni,et al.  Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients , 2000, AIDS.